Emerging Pharmacotherapies in Ovarian Cancer: Focus on Pegylated Liposomal Doxorubicin

Clinical Medicine Reviews in Women's Health
doi 10.4137/cmrwh.s5235
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Portico